statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Bitcoin

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Invesco QQQ Trust Series 1

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Exagen Inc. (NASDAQ:XGN  Free Report)  William Blair reduced their Q1 2024 earnings estimates for shares of Exagen in a note issued to investors on Monday, March 18th. William Blair...

Q1 2024 EPS Estimates for Exagen Inc. (NASDAQ:XGN) Decreased by Analyst

Q4 2023 Exagen Inc Earnings Call Transcript

Exagen (NASDAQ:XGN  Get Free Report) announced its quarterly earnings data on Monday. The company reported ($0.43) earnings per share (EPS) for the quarter, missing the consensus estimate of...

Exagen (NASDAQ:XGN) Announces Quarterly  Earnings Results, Misses Expectations By $0.02 EPS

CARLSBAD, Calif., March 18, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today reported financial results for the fourth quarter and full...

Exagen Inc. Reports Strong Fourth Quarter and Full-Year 2023 Results

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Exagen continues to execute on re-acceleration strategy, says Canaccord

Exagen Inc. (NASDAQ:XGN  Get Free Report) CFO Kamal Adawi sold 12,784 shares of the businesss stock in a transaction dated Monday, March 4th. The stock was sold at an average price of...

Exagen Inc. (NASDAQ:XGN) CFO Sells $24,417.44 in Stock

CARLSBAD, Calif., March 08, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the KeyBanc Capital Markets...

Exagen Inc. to Participate in the KeyBanc Capital Markets Life Sciences & MedTech Investor Forum

CARLSBAD, Calif., March 07, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing, will release financial results for the quarter and year ended December 31...

Exagen to Announce Fourth Quarter 2023 and Full-Year Financial Results on March 18, 2024

CARLSBAD, Calif., Jan. 30, 2024 (GLOBE NEWSWIRE) -- Exagen Inc. (Nasdaq: XGN), a leading provider of autoimmune testing solutions, today announced its participation in the BTIG MedTech, Digital...

Exagen Inc. to Participate in the 2024 BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference

Exagen Inc. (NASDAQ:XGN  Get Free Report) was the recipient of a large increase in short interest in December. As of December 31st, there was short interest totalling 24,200 shares, an...

Exagen Inc. (NASDAQ:XGN) Sees Significant Growth in Short Interest

Exagen, Inc. is a commercial-stage diagnostics company, which engages in transforming the care continuum for patients suffering from debilitating and chronic autoimmune diseases by enabling timely differential diagnosis and optimizing therapeutic intervention. It operates under the Avise brand. The company was founded by Waneta C. Tuttle and Cole Harris in 2002 and is headquartered in Vista, CA.

Volume	2,408.00
52-Wk High	$3.92
52-Wk Low	$1.30

XGN Exagen Inc

About

Feed

News

Sentiment

Earnings

Fundamentals